No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 2 genes, 3 drugs (DrugBank) and 38 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: RARA |
D02815 |
Alitretinoin |
1件: 49 |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
2 | Adipocytokine signaling pathway 8 genes, 8 drugs (DrugBank) and 75 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
3件: RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
3 | Adrenergic signaling in cardiomyocytes 1 gene, 2 drugs (DrugBank) and 13 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
4 | African trypanosomiasis 3 genes, 4 drugs (DrugBank) and 40 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
5 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 5 drugs (DrugBank) and 42 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
6 | Alcoholism 5 genes, 1 drug (DrugBank) and 7 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
7 | Aldosterone synthesis and secretion 1 gene, 1 drug (DrugBank) and 12 diseases shown |
1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
8 | Allograft rejection 6 genes, 6 drugs (DrugBank) and 48 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9 | Alzheimer disease 12 genes, 7 drugs (DrugBank) and 73 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: LPL |
D05255 |
Omega-3-acid ethyl esters |
1件: 49 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Amoebiasis 5 genes, 5 drugs (DrugBank) and 47 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | Amphetamine addiction 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
12 | AMPK signaling pathway 5 genes, 7 drugs (DrugBank) and 63 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
13 | Amyotrophic lateral sclerosis (ALS) 11 genes, 6 drugs (DrugBank) and 73 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
14 | Antifolate resistance 3 genes, 4 drugs (DrugBank) and 51 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
15 | Antigen processing and presentation 2 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: CD74 |
D08944 |
Milatuzumab |
1件: 49 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
16 | Apelin signaling pathway 3 genes, 2 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
17 | Apoptosis 1 gene, 3 drugs (DrugBank) and 38 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
18 | Arachidonic acid metabolism 2 genes, 3 drugs (DrugBank) and 17 diseases shown |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
1件: PTGS2 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
19 | Asthma 2 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
20 | Autoimmune thyroid disease 16 genes, 4 drugs (DrugBank) and 24 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
21 | Autophagy - animal 3 genes, 2 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
22 | Autophagy - other 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
23 | Axon guidance 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
24 | B cell receptor signaling pathway 7 genes, 4 drugs (DrugBank) and 55 diseases shown |
1件: CD22 |
D04036 |
Epratuzumab |
1件: 49 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
25 | Bile secretion 2 genes, 5 drugs (DrugBank) and 32 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
1件: RXRA |
D02815 |
Alitretinoin |
1件: 49 |
26 | Breast cancer 4 genes, 5 drugs (DrugBank) and 41 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
D00953 |
27 | C-type lectin receptor signaling pathway 11 genes, 10 drugs (DrugBank) and 77 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
28 | Calcium signaling pathway 11 genes, 6 drugs (DrugBank) and 65 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
4件: GRIN1, GRIN2A, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: HRH1 |
D00300 |
Diphenhydramine |
5件: 49, 51, 70, 86, 256 |
D00669 |
D02419 |
D03285 |
D03360 |
D03854 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
29 | cAMP signaling pathway 8 genes, 5 drugs (DrugBank) and 29 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
1件: PDE4A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
30 | Cell adhesion molecules (CAMs) 6 genes, 5 drugs (DrugBank) and 28 diseases shown |
1件: CD22 |
D04036 |
Epratuzumab |
1件: 49 |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
31 | Cellular senescence 6 genes, 3 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
32 | Central carbon metabolism in cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
33 | cGMP-PKG signaling pathway 7 genes, 5 drugs (DrugBank) and 60 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: PDE5A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
34 | Chagas disease (American trypanosomiasis) 4 genes, 5 drugs (DrugBank) and 45 diseases shown |
1件: ACE |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
35 | Chemical carcinogenesis 1 gene, 3 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
36 | Chemokine signaling pathway 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
2件: JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
37 | Cholesterol metabolism 2 genes, 1 drug (DrugBank) and 1 disease shown |
2件: CETP, LPL |
D05255 |
Omega-3-acid ethyl esters |
1件: 49 |
38 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
39 | Cholinergic synapse 1 gene, 2 drugs (DrugBank) and 13 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
40 | Circadian entrainment 7 genes, 2 drugs (DrugBank) and 12 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
41 | Circadian rhythm 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
42 | Cocaine addiction 5 genes, 1 drug (DrugBank) and 7 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
43 | Colorectal cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
44 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: F10 |
D07086 |
Rivaroxaban |
2件: 46, 49 |
45 | Cortisol synthesis and secretion 1 gene, 1 drug (DrugBank) and 12 diseases shown |
1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
46 | Cushing syndrome 1 gene, 1 drug (DrugBank) and 12 diseases shown |
1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
47 | Cytokine-cytokine receptor interaction 29 genes, 15 drugs (DrugBank) and 60 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: TNFRSF8 |
D09587 |
Brentuximab vedotin |
2件: 49, 51 |
2件: TNFSF13, TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
D10083 |
Tabalumab |
2件: 46, 49 |
48 | Cytosolic DNA-sensing pathway 13 genes, 2 drugs (DrugBank) and 1 disease shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
49 | Dilated cardiomyopathy (DCM) 1 gene, 3 drugs (DrugBank) and 38 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
50 | DNA replication 2 genes, 1 drug (DrugBank) and 9 diseases shown |
2件: POLA1, POLA2 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
51 | Dopaminergic synapse 5 genes, 3 drugs (DrugBank) and 59 diseases shown |
2件: GRIN2A, GRIN2B |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
52 | Drug metabolism - other enzymes 3 genes, 5 drugs (DrugBank) and 39 diseases shown |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
53 | EGFR tyrosine kinase inhibitor resistance 3 genes, 4 drugs (DrugBank) and 45 diseases shown |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
54 | Endocrine and other factor-regulated calcium reabsorption 2 genes, 6 drugs (DrugBank) and 26 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
55 | Endocrine resistance 3 genes, 4 drugs (DrugBank) and 41 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
56 | Endocytosis 3 genes, 1 drug (DrugBank) and 4 diseases shown |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
57 | Epstein-Barr virus infection 22 genes, 12 drugs (DrugBank) and 46 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
58 | ErbB signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
59 | Estrogen signaling pathway 4 genes, 6 drugs (DrugBank) and 11 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
D00953 |
1件: RARA |
D02815 |
Alitretinoin |
1件: 49 |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
60 | Fat digestion and absorption 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: NPC1L1 |
D01966 |
Ezetimibe |
4件: 49, 79, 93, 260 |
61 | Fc epsilon RI signaling pathway 2 genes, 4 drugs (DrugBank) and 40 diseases shown |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
62 | Fc gamma R-mediated phagocytosis 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
63 | Fluid shear stress and atherosclerosis 7 genes, 7 drugs (DrugBank) and 61 diseases shown |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
64 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
65 | FoxO signaling pathway 3 genes, 2 drugs (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: S1PR1 |
D11283 |
Cenerimod |
1件: 49 |
66 | Gap junction 9 genes, 1 drug (DrugBank) and 2 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D09587 |
Brentuximab vedotin |
2件: 49, 51 |
67 | Gastric cancer 5 genes, 3 drugs (DrugBank) and 38 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
4件: RARB, RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
68 | Glioma 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
69 | Glucagon signaling pathway 7 genes, 3 drugs (DrugBank) and 64 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
70 | Glutamatergic synapse 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
71 | Glutathione metabolism 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
72 | Glycerolipid metabolism 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: LPL |
D05255 |
Omega-3-acid ethyl esters |
1件: 49 |
73 | GnRH secretion 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
74 | GnRH signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: GNRHR |
D06247 |
Triptorelin |
2件: 49, 76 |
75 | Graft-versus-host disease 3 genes, 4 drugs (DrugBank) and 48 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
76 | Growth hormone synthesis, secretion and action 2 genes, 3 drugs (DrugBank) and 45 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
77 | Hematopoietic cell lineage 7 genes, 9 drugs (DrugBank) and 71 diseases shown |
1件: CD22 |
D04036 |
Epratuzumab |
1件: 49 |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: IL2RA |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: MS4A1 |
D05218 |
Ocrelizumab |
3件: 13, 46, 49 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
78 | Hepatitis B 19 genes, 9 drugs (DrugBank) and 42 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
1件: IFNAR1 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
79 | Hepatitis C 19 genes, 10 drugs (DrugBank) and 42 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: RXRA |
D02815 |
Alitretinoin |
1件: 49 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
80 | Hepatocellular carcinoma 3 genes, 3 drugs (DrugBank) and 40 diseases shown |
1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
81 | Herpes simplex virus 1 infection 24 genes, 13 drugs (DrugBank) and 66 diseases shown |
1件: CD74 |
D08944 |
Milatuzumab |
1件: 49 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
82 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
83 | Human cytomegalovirus infection 23 genes, 15 drugs (DrugBank) and 93 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
84 | Human immunodeficiency virus 1 infection 20 genes, 8 drugs (DrugBank) and 81 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
85 | Human papillomavirus infection 20 genes, 13 drugs (DrugBank) and 73 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
86 | Human T-cell leukemia virus 1 infection 16 genes, 13 drugs (DrugBank) and 76 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: FDPS |
D08056 |
Ibandronate |
2件: 46, 49 |
2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
87 | Huntington disease 3 genes, 2 drugs (DrugBank) and 20 diseases shown |
2件: GRIN1, GRIN2B |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
88 | Hypertrophic cardiomyopathy (HCM) 4 genes, 5 drugs (DrugBank) and 56 diseases shown |
1件: ACE |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
89 | IL-17 signaling pathway 2 genes, 6 drugs (DrugBank) and 49 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
90 | Inflammatory bowel disease (IBD) 5 genes, 5 drugs (DrugBank) and 40 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
91 | Inflammatory mediator regulation of TRP channels 2 genes, 2 drugs (DrugBank) and 20 diseases shown |
1件: HRH1 |
D00300 |
Diphenhydramine |
5件: 49, 51, 70, 86, 256 |
D00669 |
D02419 |
D03285 |
D03360 |
D03854 |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
92 | Influenza A 22 genes, 11 drugs (DrugBank) and 43 diseases shown |
1件: FDPS |
D08056 |
Ibandronate |
2件: 46, 49 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
93 | Insulin resistance 4 genes, 5 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
94 | Insulin signaling pathway 3 genes, 2 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
95 | Intestinal immune network for IgA production 5 genes, 5 drugs (DrugBank) and 26 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: TNFSF13, TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
D10083 |
Tabalumab |
2件: 46, 49 |
96 | JAK-STAT signaling pathway 27 genes, 10 drugs (DrugBank) and 61 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
97 | Kaposi sarcoma-associated herpesvirus infection 27 genes, 14 drugs (DrugBank) and 86 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
98 | Legionellosis 3 genes, 4 drugs (DrugBank) and 40 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
99 | Leishmaniasis 6 genes, 10 drugs (DrugBank) and 53 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
100 | Leukocyte transendothelial migration 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
101 | Long-term potentiation 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
102 | Longevity regulating pathway 4 genes, 3 drugs (DrugBank) and 50 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
103 | Longevity regulating pathway - multiple species 3 genes, 2 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
104 | Malaria 4 genes, 6 drugs (DrugBank) and 42 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
105 | MAPK signaling pathway 7 genes, 6 drugs (DrugBank) and 73 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
106 | Measles 23 genes, 8 drugs (DrugBank) and 21 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
107 | Metabolic pathways 14 genes, 17 drugs (DrugBank) and 76 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
1件: FDPS |
D08056 |
Ibandronate |
2件: 46, 49 |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
2件: PDE4A, PDE5A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
1件: PTGS2 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
108 | MicroRNAs in cancer 2 genes, 4 drugs (DrugBank) and 44 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
109 | Mineral absorption 1 gene, 3 drugs (DrugBank) and 22 diseases shown |
1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
110 | Morphine addiction 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: PDE4A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
111 | mTOR signaling pathway 4 genes, 5 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
112 | Natural killer cell mediated cytotoxicity 23 genes, 10 drugs (DrugBank) and 69 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
113 | Necroptosis 20 genes, 9 drugs (DrugBank) and 42 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
114 | Neuroactive ligand-receptor interaction 15 genes, 13 drugs (DrugBank) and 71 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
1件: GNRHR |
D06247 |
Triptorelin |
2件: 49, 76 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: HRH1 |
D00300 |
Diphenhydramine |
5件: 49, 51, 70, 86, 256 |
D00669 |
D02419 |
D03285 |
D03360 |
D03854 |
1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
1件: NR3C1 |
D00407 |
Methylprednisolone |
36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
D00751 |
D00979 |
D05000 |
D05001 |
D05002 |
D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
D00980 |
D00981 |
D00982 |
D01239 |
D01998 |
D02156 |
D03301 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
D08416 |
Prednisone acetate |
6件: 35, 40, 41, 49, 162, 224 |
1件: S1PR1 |
D11283 |
Cenerimod |
1件: 49 |
2件: THRA, THRB |
D01010 |
Levothyroxine |
2件: 49, 78 |
D08125 |
115 | NF-kappa B signaling pathway 6 genes, 12 drugs (DrugBank) and 60 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
D10083 |
Tabalumab |
2件: 46, 49 |
116 | Nicotine addiction 5 genes, 1 drug (DrugBank) and 7 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
117 | NOD-like receptor signaling pathway 18 genes, 9 drugs (DrugBank) and 42 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
118 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 5 drugs (DrugBank) and 53 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: RXRA |
D02815 |
Alitretinoin |
1件: 49 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
119 | Non-small cell lung cancer 5 genes, 3 drugs (DrugBank) and 12 diseases shown |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
4件: RARB, RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
120 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
121 | Oocyte meiosis 7 genes, 4 drugs (DrugBank) and 56 diseases shown |
1件: AR |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
D00953 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
122 | Osteoclast differentiation 13 genes, 12 drugs (DrugBank) and 81 diseases shown |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
123 | Ovarian steroidogenesis 1 gene, 3 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
124 | Oxytocin signaling pathway 8 genes, 6 drugs (DrugBank) and 73 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
125 | Pancreatic cancer 2 genes, 4 drugs (DrugBank) and 45 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
126 | Parathyroid hormone synthesis, secretion and action 5 genes, 5 drugs (DrugBank) and 24 diseases shown |
1件: PDE4A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
3件: RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
127 | Pathogenic Escherichia coli infection 11 genes, 5 drugs (DrugBank) and 46 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D09587 |
Brentuximab vedotin |
2件: 49, 51 |
128 | Pathways in cancer 38 genes, 21 drugs (DrugBank) and 78 diseases shown |
3件: AR, ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
2件: RARA, RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
5件: RARA, RARB, RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
129 | PD-L1 expression and PD-1 checkpoint pathway in cancer 9 genes, 7 drugs (DrugBank) and 78 diseases shown |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
130 | Pertussis 4 genes, 4 drugs (DrugBank) and 40 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
131 | Phagosome 9 genes, 1 drug (DrugBank) and 2 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D09587 |
Brentuximab vedotin |
2件: 49, 51 |
132 | Phospholipase D signaling pathway 2 genes, 2 drugs (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
133 | PI3K-Akt signaling pathway 27 genes, 12 drugs (DrugBank) and 63 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: RXRA |
D02815 |
Alitretinoin |
1件: 49 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
134 | Platelet activation 3 genes, 4 drugs (DrugBank) and 18 diseases shown |
1件: P2RY12 |
D00769 |
Clopidogrel |
2件: 49, 86 |
D07729 |
D10823 |
D10824 |
1件: PTGS1 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
135 | PPAR signaling pathway 5 genes, 3 drugs (DrugBank) and 17 diseases shown |
1件: LPL |
D05255 |
Omega-3-acid ethyl esters |
1件: 49 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
3件: RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
136 | Primary immunodeficiency 3 genes, 3 drugs (DrugBank) and 11 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
137 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
D00953 |
138 | Prolactin signaling pathway 3 genes, 5 drugs (DrugBank) and 20 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
139 | Prostate cancer 3 genes, 3 drugs (DrugBank) and 49 diseases shown |
1件: AR |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
140 | Proteasome 1 gene, 1 drug (DrugBank) and 13 diseases shown |
1件: PSMB5 |
D03150 |
Bortezomib |
13件: 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
141 | Proteoglycans in cancer 4 genes, 8 drugs (DrugBank) and 67 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
142 | Purine metabolism 5 genes, 6 drugs (DrugBank) and 39 diseases shown |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
2件: PDE4A, PDE5A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
143 | Pyrimidine metabolism 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
144 | Rap1 signaling pathway 4 genes, 2 drugs (DrugBank) and 14 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
145 | Ras signaling pathway 3 genes, 1 drug (DrugBank) and 7 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
146 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
147 | Regulation of lipolysis in adipocytes 3 genes, 5 drugs (DrugBank) and 23 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
1件: PTGS2 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
148 | Renin secretion 7 genes, 5 drugs (DrugBank) and 63 diseases shown |
1件: ACE |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
149 | Renin-angiotensin system 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: ACE |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
150 | Retrograde endocannabinoid signaling 1 gene, 3 drugs (DrugBank) and 17 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
151 | Rheumatoid arthritis 7 genes, 9 drugs (DrugBank) and 50 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
2件: TNFSF13, TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
D10083 |
Tabalumab |
2件: 46, 49 |
152 | RIG-I-like receptor signaling pathway 16 genes, 6 drugs (DrugBank) and 40 diseases shown |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
153 | Salivary secretion 1 gene, 2 drugs (DrugBank) and 13 diseases shown |
1件: ADRB2 |
D08124 |
Levosalbutamol |
1件: 49 |
D02147 |
Salbutamol |
13件: 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
154 | Serotonergic synapse 3 genes, 5 drugs (DrugBank) and 17 diseases shown |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
1件: PTGS2 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: SLC6A4 |
D01179 |
Duloxetine |
3件: 6, 13, 49 |
D07880 |
D08222 |
Milnacipran |
2件: 46, 49 |
155 | Shigellosis 3 genes, 5 drugs (DrugBank) and 67 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
156 | Signaling pathways regulating pluripotency of stem cells 3 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
157 | Small cell lung cancer 5 genes, 5 drugs (DrugBank) and 19 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
4件: RARB, RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
158 | Sphingolipid signaling pathway 2 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: S1PR1 |
D11283 |
Cenerimod |
1件: 49 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
159 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
160 | Synaptic vesicle cycle 2 genes, 2 drugs (DrugBank) and 4 diseases shown |
2件: SLC6A2, SLC6A4 |
D01179 |
Duloxetine |
3件: 6, 13, 49 |
D07880 |
D08222 |
Milnacipran |
2件: 46, 49 |
161 | Systemic lupus erythematosus 6 genes, 6 drugs (DrugBank) and 52 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: GRIN2A, GRIN2B |
D04905 |
Memantine |
7件: 2, 6, 8, 13, 49, 127, 205 |
D08174 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
162 | T cell receptor signaling pathway 7 genes, 6 drugs (DrugBank) and 69 diseases shown |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
163 | Terpenoid backbone biosynthesis 2 genes, 5 drugs (DrugBank) and 32 diseases shown |
1件: FDPS |
D08056 |
Ibandronate |
2件: 46, 49 |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
164 | TGF-beta signaling pathway 1 gene, 3 drugs (DrugBank) and 38 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
165 | Th1 and Th2 cell differentiation 14 genes, 7 drugs (DrugBank) and 62 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
166 | Th17 cell differentiation 19 genes, 11 drugs (DrugBank) and 81 diseases shown |
1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
4件: RARA, RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
167 | Thermogenesis 4 genes, 3 drugs (DrugBank) and 50 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
168 | Thyroid cancer 4 genes, 2 drugs (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
3件: RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
169 | Thyroid hormone signaling pathway 7 genes, 6 drugs (DrugBank) and 42 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
D01413 |
D01617 |
D01953 |
D04061 |
D04063 |
D04064 |
D04065 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
3件: RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
2件: THRA, THRB |
D01010 |
Levothyroxine |
2件: 49, 78 |
D08125 |
170 | Tight junction 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
171 | TNF signaling pathway 2 genes, 6 drugs (DrugBank) and 49 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
172 | Toll-like receptor signaling pathway 21 genes, 9 drugs (DrugBank) and 48 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
173 | Toxoplasmosis 7 genes, 8 drugs (DrugBank) and 43 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
174 | Transcriptional misregulation in cancer 9 genes, 7 drugs (DrugBank) and 41 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
1件: IL2RB |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
4件: RARA, RXRA, RXRB, RXRG |
D02815 |
Alitretinoin |
1件: 49 |
175 | Tuberculosis 27 genes, 16 drugs (DrugBank) and 75 diseases shown |
1件: CD74 |
D08944 |
Milatuzumab |
1件: 49 |
13件: IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 |
D09662 |
Rontalizumab |
1件: 49 |
D09668 |
Sifalimumab |
1件: 49 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
176 | Type I diabetes mellitus 5 genes, 5 drugs (DrugBank) and 48 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
177 | Type II diabetes mellitus 2 genes, 4 drugs (DrugBank) and 62 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
178 | Ubiquinone and other terpenoid-quinone biosynthesis 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
D01280 |
D08682 |
179 | Ubiquitin mediated proteolysis 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
180 | VEGF signaling pathway 6 genes, 5 drugs (DrugBank) and 65 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
181 | Viral carcinogenesis 3 genes, 4 drugs (DrugBank) and 15 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
182 | Viral myocarditis 4 genes, 3 drugs (DrugBank) and 27 diseases shown |
1件: CD40 |
D11610 |
Iscalimab |
1件: 49 |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
183 | Viral protein interaction with cytokine and cytokine receptor 4 genes, 4 drugs (DrugBank) and 38 diseases shown |
3件: IL2RA, IL2RB, IL2RG |
D00748 |
Aldesleukin |
4件: 2, 49, 65, 97 |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
184 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
185 | Yersinia infection 1 gene, 3 drugs (DrugBank) and 38 diseases shown |
1件: TNF |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |